Low Basal Body Temperature
Conditions
Brief summary
We aim to determine whether a supplement containing fucoidan isolated from Mekabu (sporophyll of Undaria pinnatifida), EPA, and DHA has effects of elevating basal body temperature in subjects with low basal body temperature.
Interventions
75 mg fucoidan per day, for 8 weeks
for 8 weeks
Sponsors
Study design
Eligibility
Inclusion criteria
* Postmenopausal women with basal body temperature \< 36.0 ºC * Healthy as based on medical history and physical examination * Willing not to donate blood during the study * Informed consent signed
Exclusion criteria
* Renal or hepatic dysfunction * Heart disease * Participation in any clinical trial within 90 days of the commencement of the trial * Subjects who are taking medicines or functional food that may affect basal body temperature
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Basal body temperature | up to 20 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Change from baseline in serum lipid levels (total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride) | Weeks 0, 8, 12, and 20 |
Countries
Japan